Serum institute CEO expects Omicron-specific vaccine in 6 months: Report

Published On 2022-08-17 05:30 GMT   |   Update On 2022-08-17 15:20 GMT

New Delhi: Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday. Read also: SII conducting research to find vaccine against Monkeypox, says Adar PoonawallaSII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield. SII did...

Login or Register to read the full article

New Delhi: Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday. 

Read also: SII conducting research to find vaccine against Monkeypox, says Adar Poonawalla

SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield. 

SII did not immediately respond to a Reuters request for comment.

Read also: Centre plans to roll out SII qHPV vaccine for girls aged 9-14 years under National Immunization Programme


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News